Biomarkers for Community-Acquired Pneumonia in the Emergency Department
Abstract Community-acquired pneumonia is one of the most common reasons for emergency department (ED) visits in children and adults. Despite its prevalence, there are many challenges to proper diagnosis and management of pneumonia. There is no accurate and timely etiologic gold standard to differentiate bacterial from viral disease, and there are limitations with precise risk stratification of patients to ensure appropriate site-of-care decisions. Clinical factors obtained by history and physical examination have limited the ability to diagnose pneumonia etiology and severity. Biomarkers offer information about the host response to infection and pathogen activity within the host that can serve to augment clinical features in decision-making. As science and technology progress, novel biomarkers offer great potential in aiding critical decisions for patients with pneumonia. This review summarizes existing knowledge about biomarkers of host response and pathogen activity, in addition to briefly reviewing emerging biomarkers using novel technologies..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Current infectious disease reports - 16(2014), 12 vom: 28. Okt. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Florin, Todd A. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| doi: |
10.1007/s11908-014-0451-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR022965556 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR022965556 | ||
| 003 | DE-627 | ||
| 005 | 20230519160705.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201006s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11908-014-0451-8 |2 doi | |
| 035 | |a (DE-627)SPR022965556 | ||
| 035 | |a (SPR)s11908-014-0451-8-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.75 |2 bkl | ||
| 100 | 1 | |a Florin, Todd A. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Biomarkers for Community-Acquired Pneumonia in the Emergency Department |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Community-acquired pneumonia is one of the most common reasons for emergency department (ED) visits in children and adults. Despite its prevalence, there are many challenges to proper diagnosis and management of pneumonia. There is no accurate and timely etiologic gold standard to differentiate bacterial from viral disease, and there are limitations with precise risk stratification of patients to ensure appropriate site-of-care decisions. Clinical factors obtained by history and physical examination have limited the ability to diagnose pneumonia etiology and severity. Biomarkers offer information about the host response to infection and pathogen activity within the host that can serve to augment clinical features in decision-making. As science and technology progress, novel biomarkers offer great potential in aiding critical decisions for patients with pneumonia. This review summarizes existing knowledge about biomarkers of host response and pathogen activity, in addition to briefly reviewing emerging biomarkers using novel technologies. | ||
| 650 | 4 | |a Community-acquired pneumonia |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Biomarkers |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Leukocyte count |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a C-reactive protein |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Procalcitonin |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Proadrenomedullin |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Diagnostic testing |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Blood cultures |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Sputum cultures |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Polymerase chain reaction |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Emergency medicine |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Transcriptomics |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Metabolomics |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Pediatric |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Adult |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Ambroggio, Lilliam |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current infectious disease reports |d Heidelberg [u.a.] : Springer, 1999 |g 16(2014), 12 vom: 28. Okt. |w (DE-627)SPR022959068 |w (DE-600)2094167-5 |x 1534-3146 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2014 |g number:12 |g day:28 |g month:10 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11908-014-0451-8 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.75 |q ASE |
| 951 | |a AR | ||
| 952 | |d 16 |j 2014 |e 12 |b 28 |c 10 | ||